La Rosa Holdings Corp. 8-K

What Happened
La Rosa Holdings Corp. announced on June 12, 2026 (8-K) that Nasdaq’s Listing Qualifications Staff notified the company it is noncompliant with Nasdaq Rule 5250(c)(1) because it remains delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The company filed its Annual Report on Form 10-K for the year ended December 31, 2025 on June 4, 2026, and Nasdaq determined the Form 10-K is compliant, but the Form 10-Q is still outstanding. La Rosa submitted a plan of compliance to Nasdaq on June 11, 2026 and says it intends to file the Form 10-Q as soon as practicable.

Key Details

• Delinquent filing: Form 10-Q for quarter ended March 31, 2026 remains not filed; company submitted compliance plan on June 11, 2026.
• 10-K filed: Form 10-K for year ended December 31, 2025 was filed June 4, 2026; Nasdaq found the 10-K compliant.
• Equity deficiency: Stockholders’ equity reported at $(1,848,252) in the 2025 Form 10-K, below Nasdaq Capital Market minimum of $2,500,000 (Rule 5550(b)(1)).
• Deadlines: Nasdaq gave 45 days (until July 27, 2026) to submit a plan for the equity deficiency; if accepted, up to 180 days (until Dec 7, 2026) may be granted to evidence compliance. For the delinquent reports Nasdaq may grant up to 180 days from the 10-K due date (until Oct 12, 2026) to regain compliance.

Why It Matters
Nasdaq’s notices do not immediately delist the stock — La Rosa’s common shares remain listed under ticker LRHC — but they signal material compliance and financial condition issues that the company must resolve to remain listed. For investors, the two main risks are (1) continued delinquent reporting, which can reduce transparency about operations and financials, and (2) a negative shareholders’ equity position, which indicates the company does not meet Nasdaq’s minimum capitalization requirement and could lead to delisting if not remedied. The company has the right to appeal any adverse Nasdaq decision, but there is no assurance of a successful appeal.